✦ LIBER ✦

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

✍ Scribed by M. Manns; H. Reesink; C. Moreno; T. Berg; Y. Benhamou; Y. Horsmans; G. Dusheiko; R. Flisiak; P. Meyvisch; O. Lenz; V. Sekar; G. van't Klooster; K. Simmen; R. Verloes

Book ID: 117377022
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 51 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60013-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1075 PHARMACOKINETIC-PHARMACODYNAMIC (PK

1075 PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) ANALYSES OF TMC435 IN TREATMENT-NAIVE HEPATITIS C (HCV)-INFECTED PATIENTS IN THE OPERA-1 STUDY

✍ Sekar, V.; Vis, P.; Lenz, O.; Meyvisch, P.; Peeters, M.; De Smedt, G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS

✍ M. Rodriguez-Torres; E. Lawitz; B. Conway; K. Kaita; A.M. Sheikh; R. Ghalib; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

P1127 SIMEPREVIR (TMC435) WITH PEGINTERF

P1127 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION IN TREATMENT-NAIVE EUROPEAN PATIENTS IN THE QUEST-1 AND QUEST-2 PHASE III TRIALS

✍ Foster, G.R.; Jacobson, I.M.; Dore, G.J.; Fried, M.; Manns, M.; Marcellin, P.; P 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 68 KB

869a Simeprevir (TMC435) With Peginterfe

869a Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype-1 Infection in Treatment-Naive Patients: Results From QUEST-2, a Phase III Trial

✍ Poordad, Fred; Manns, Michael P.; Marcellin, Patrick; de Araujo, Evaldo Stanisla 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 231 KB

2009 SAFETY AND ANTIVIRAL ACTIVITY OF AN

2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS

✍ Lawitz, E.; Rodriquez-Torres, M.; Rustgi, V.K.; Hassanein, T.; Rahimy, M.H.; Cro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

11 IMPACT OF IL28B GENOTYPE AND PRETREAT

11 IMPACT OF IL28B GENOTYPE AND PRETREATMENT SERUM IP-10 IN TREATMENT-NAIVE GENOTYPE-1 HCV PATIENTS TREATED WITH TMC435 IN COMBINATION WITH PEGINTERFERONa-2A AND RIBAVIRIN IN PILLAR STUDY

✍ J. Aerssens; G. Fanning; A. Scholliers; O. Lenz; M. Peeters; G. De Srnedt; M. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB